Inotersen Interactions
There are 237 drugs known to interact with inotersen, along with 5 disease interactions. Of the total drug interactions, 183 are major, and 54 are moderate.
- View inotersen disease interactions (5)
Medications known to interact with inotersen
Note: Showing generic names only.
A
- abciximab
- acalabrutinib
- acyclovir
- adefovir
- ado-trastuzumab emtansine
- aldesleukin
- alteplase
- amikacin
- amikacin liposome
- amphotericin b
- amphotericin b cholesteryl sulfate
- amphotericin b lipid complex
- amphotericin b liposomal
- anagrelide
- anisindione
- anistreplase
- antithrombin (recombinant)
- antithrombin iii
- apixaban
- ardeparin
- argatroban
- aspirin
- avapritinib
B
- bacitracin
- balsalazide
- bedaquiline
- betrixaban
- binimetinib
- bivalirudin
- black cohosh
- botulism immune globulin
- brentuximab
- bromfenac
- bromfenac ophthalmic
C
- cabozantinib
- cangrelor
- cannabidiol
- caplacizumab
- capreomycin
- carboplatin
- celecoxib
- cidofovir
- cilostazol
- cisplatin
- citalopram
- clofarabine
- clomipramine
- clopidogrel
- colistimethate
- cyclophosphamide
- cyclosporine
- cytomegalovirus immune globulin
D
- dabigatran
- daclizumab
- dalteparin
- danaparoid
- dasatinib
- deferasirox
- deferoxamine
- defibrotide
- deoxycholic acid
- desirudin
- desvenlafaxine
- dexfenfluramine
- diatrizoate
- diclofenac
- diclofenac ophthalmic
- diclofenac topical
- dicumarol
- diflunisal
- dimethyl fumarate
- dipyridamole
- diroximel fumarate
- drotrecogin alfa
- duloxetine
E
- edetate calcium disodium
- edetate disodium (edta)
- edoxaban
- efavirenz
- encorafenib
- enoxaparin
- entecavir
- epirubicin
- epoprostenol
- eptifibatide
- escitalopram
- etidronate
- etodolac
- everolimus
- exenatide
F
- fedratinib
- fenfluramine
- fenoprofen
- flucytosine
- fluoxetine
- flurbiprofen
- flurbiprofen ophthalmic
- fluvoxamine
- fondaparinux
- foscarnet
G
H
I
- ibandronate
- ibritumomab
- ibrutinib
- ibuprofen
- idelalisib
- ifosfamide
- iloprost
- immune globulin intravenous
- immune globulin intravenous and subcutaneous
- indomethacin
- interferon beta-1a
- interferon beta-1b
- iobenguane I 131
- iodamide
- iodine i 131 tositumomab
- iodipamide
- iodixanol
- iohexol
- iomeprol
- iopamidol
- iopromide
- iothalamate
- ioversol
- ioxaglate
- ioxilan
K
L
- leflunomide
- lepirudin
- levomilnacipran
- lifileucel
- lithium
- lomitapide
- lutetium lu 177 dotatate
- lutetium lu 177 vipivotide tetraxetan
M
- meclofenamate
- mefenamic acid
- meloxicam
- mesalamine
- methotrexate
- methoxyflurane
- metrizamide
- milnacipran
- mipomersen
- monomethyl fumarate
- moxetumomab pasudotox
N
O
P
- pamidronate
- panobinostat
- paroxetine
- peginterferon beta-1a
- pemetrexed
- penicillamine
- pentamidine
- pentosan polysulfate sodium
- pentoxifylline
- phenylbutazone
- piroxicam
- plazomicin
- plicamycin
- polymyxin b
- ponatinib
- prasugrel
R
- ramucirumab
- regorafenib
- remdesivir
- respiratory syncytial virus immune globulin
- reteplase
- rho (d) immune globulin
- rivaroxaban
- rofecoxib
- ruxolitinib
S
- salsalate
- sertraline
- sibutramine
- sirolimus
- streptokinase
- streptomycin
- streptozocin
- sulfasalazine
- sulfinpyrazone
- sulindac
- suprofen ophthalmic
T
- tacrolimus
- tazemetostat
- telavancin
- telbivudine
- temsirolimus
- tenecteplase
- tenofovir alafenamide
- tenofovir disoproxil
- teriflunomide
- thioguanine
- ticagrelor
- ticlopidine
- tinzaparin
- tipranavir
- tirofiban
- tobramycin
- tolmetin
- tositumomab
- tovorafenib
- trabectedin
- treprostinil
- turmeric
U
V
- valacyclovir
- valdecoxib
- valganciclovir
- vancomycin
- venlafaxine
- vilazodone
- voclosporin
- vorapaxar
- vortioxetine
W
Z
Inotersen disease interactions
There are 5 disease interactions with inotersen which include:
More about inotersen
- inotersen consumer information
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: miscellaneous metabolic agents
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.